# Shared Resources Core: Puerto Rico Biobank

> **NIH NIH U54** · H. LEE MOFFITT CANCER CTR & RES INST · 2021 · $150,129

## Abstract

PROJECT SUMMARY/ABSTRACT 
 In order to move closer to achieving the goals of precision medicine and individualized cancer care, 
participation in biobanking from large numbers of individuals representing all ethnicities is essential. The 
scarcity of tissues available at existing biobanks from racial and ethnic minorities poses a substantial constraint 
to conducting research needed to understand the biological basis of health disparities. Because cancer- 
causing genetic alterations vary across individuals and ethnicities, the practice of precision medicine requires 
knowledge acquired through the study of tumor tissue derived from individuals representing diverse 
populations. It is important to recognize that Hispanic/Latino (H/L) ethnicity is an admixture of European, 
African, and Amerindians ancestral genomes, the proportions of which vary widely across individuals from 
different geographical regions. Also, there are differences in cancer trends associated to cancer biology and 
admixture genetics among different H/L sub-populations. Despite being a large proportion of the ethnic 
minorities living in the US, to date, there has been no comprehensive availability of tumor tissue from H/L 
cancer patients in national biobanks. To address this disparity, we propose to continue to develop the existing 
research infrastructure of the Puerto Rico Biobank (PRBB) to support research initiatives designed to 
understand the biological basis of cancer health disparities. The purpose of the PRBB is to facilitate the optimal 
collection, processing, storage, and distribution of well-annotated human biospecimens derived from the 
island’s H/L population for use in investigator-initiated translational cancer research. Throughout the past 10 
years, a solid infrastructure has been put in place to develop this unique biorepository in Puerto Rico. Through 
this resource, fresh frozen tissues, paraffin blocks, high-quality tumor-derived RNA, genomic DNA, and clinical 
and risk factor information are available to support research at both institutions focusing on molecular aspects 
and determinants of cancer health disparities involving H/L living in Florida and Puerto Rico. 
 We propose to expand the existing Partnership’s biobank via three Specific Aims. In Aim 1 we propose 
to continue the collection, processing, storage, and distribution of biospecimens in collaboration with local 
hospitals and clinics. In cooperation with the Partnership’s Outreach Core, efforts to consent healthy 
individuals during community outreach educational activities will continue. In Aim 2, we propose to extend the 
documentation of demographic, clinical, pathological, and molecular data (‘omic’, ancestry, next-gen sequence 
data) in collaboration with the Quantitative Sciences Core. In Aim 3, we propose to foster new collaborative 
research projects focused on cancer research. As facilitator of translational research, the PRBB is placed at 
the forefront of the Precision Medici...

## Key facts

- **NIH application ID:** 10249099
- **Project number:** 5U54CA163068-10
- **Recipient organization:** H. LEE MOFFITT CANCER CTR & RES INST
- **Principal Investigator:** William Douglas Cress
- **Activity code:** U54 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $150,129
- **Award type:** 5
- **Project period:** 2012-09-24 → 2023-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10249099

## Citation

> US National Institutes of Health, RePORTER application 10249099, Shared Resources Core: Puerto Rico Biobank (5U54CA163068-10). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10249099. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
